Pax-2 expression in adult renal tumors

Human Pathology

Volumn 32, Issue 3, 2001, Pages 282-287

  Daniel, Laurent ^a   Lechevallier, Eric ^a   Giorgi, Roch ^a   Sichez, Hélène ^a   Zattara Cannoni, Hélène ^a   Figarella Branger, Dominique ^a   Coulange, Christian ^b  

^a Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Oncogene; Pax 2; Proliferation; Renal tumors; Transforming growth factor 1

Indexed keywords

KI 67 ANTIGEN; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ADULT DISEASE; AGED; ARTICLE; CANCER GRADING; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HOMEOBOX; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE; TUMOR LOCALIZATION;

EID: 0035078613     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.22753     Document Type: Article

References (32)

1. Pax-2, kidney development and oncogenesis
2. The genomic organization of the WT1 gene
3. Pax-2 a new murine paired box containing gene and its expression in the developing excretory system
4. The role of Pax-2 in normal and abnormal development of the urinary tract
5. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities
6. The oncogenic potential of Pax genes
7. Expression of Pax-2 in human renal cell carcinoma and inhibition by antisense oligonucleotides
8. Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells
9. TNM staging of renal cell carcinoma: Workgroup no 3
10. Classification of renal cell carcinoma: Workgroup no 1
11. Prognostic significance of morphologic parameters in renal cell carcinomas
12. Tumor proliferative fraction solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometry determination
13. Pax genes in development
14. Gene fusion encoding chimaeric transcription factors in solid tumours
15. Paired box gene expression in Wilms' tumor
16. Repression of Pax-2 by WT1 during normal kidney development
17. Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma
18. TGF-β in kidney fibrosis: A target for gene therapy
19. Changes in collagenases and TGF-beta precede structural alterations in a model of chronic renal fibrosis
20. Acquisition of TGF-β1 resistance: An important factor in human renal cell carcinoma
21. The cell biology of transforming growth factor β
22. Increased transforming growth factor beta-1 plasma level in patients with renal cell carcinoma: A tumor specific marker?
23. Molecular cytogenetics of renal tumours
24. Cytogenetic analysis of epithelial renal cell tumors: Relationship with a new histological classification
25. Loss of heterozygoty at the short arm of chromosome 3 in renal cell cancer correlates with cytological tumor type
26. On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma
27. Cytogenetic analysis of 11 renal oncocytomas: Further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly
28. Chromosomal changes in renal oncocytomas: Evidence that t(5; 11)(q35; q13) may characterizes a second subgroup of oncocytomas
29. Molecular cytogenetics of t(X;1)(p11.2;q21) with complex rearrangements in a renal cell carcinoma
30. Expression of the Pax-2 gene in human fetal kidney and Wilms' tumor
31. Renal cell carcinoma of native kidneys: Prospective study of 129 renal transplant patients
32. Renal cell carcinoma: Prognostic significance of incidentally detected tumors